Name | Number of supported studies | Average coverage | |
---|---|---|---|
natural killer cell | 22 studies | 26% ± 8% | |
classical monocyte | 13 studies | 29% ± 11% | |
CD16-positive, CD56-dim natural killer cell, human | 12 studies | 29% ± 8% | |
non-classical monocyte | 11 studies | 24% ± 9% | |
CD16-negative, CD56-bright natural killer cell, human | 10 studies | 30% ± 8% | |
CD8-positive, alpha-beta T cell | 8 studies | 18% ± 3% | |
mature NK T cell | 7 studies | 25% ± 7% | |
gamma-delta T cell | 6 studies | 23% ± 7% | |
macrophage | 5 studies | 22% ± 7% | |
conventional dendritic cell | 4 studies | 32% ± 10% | |
hematopoietic precursor cell | 4 studies | 22% ± 3% | |
myeloid cell | 4 studies | 32% ± 11% | |
epithelial cell | 4 studies | 24% ± 5% | |
monocyte | 4 studies | 21% ± 5% | |
platelet | 3 studies | 22% ± 9% | |
effector CD8-positive, alpha-beta T cell | 3 studies | 25% ± 2% | |
megakaryocyte | 3 studies | 23% ± 8% | |
basal cell | 3 studies | 25% ± 10% | |
hematopoietic stem cell | 3 studies | 20% ± 2% | |
double negative thymocyte | 3 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 5250.29 | 653 / 653 | 100% | 82.05 | 605 / 605 |
ovary | 100% | 3474.21 | 180 / 180 | 100% | 57.28 | 428 / 430 |
esophagus | 100% | 3314.64 | 1438 / 1445 | 100% | 191.20 | 183 / 183 |
uterus | 100% | 3054.77 | 170 / 170 | 99% | 95.83 | 456 / 459 |
skin | 100% | 4009.95 | 1807 / 1809 | 99% | 89.75 | 469 / 472 |
adrenal gland | 100% | 6148.26 | 258 / 258 | 99% | 77.15 | 227 / 230 |
breast | 100% | 3094.59 | 459 / 459 | 99% | 71.87 | 1102 / 1118 |
lung | 99% | 3816.78 | 575 / 578 | 99% | 174.79 | 1141 / 1155 |
intestine | 99% | 1617.73 | 956 / 966 | 99% | 54.76 | 523 / 527 |
prostate | 100% | 2290.46 | 244 / 245 | 99% | 36.37 | 495 / 502 |
bladder | 100% | 5229.29 | 21 / 21 | 97% | 102.38 | 491 / 504 |
brain | 97% | 2015.69 | 2558 / 2642 | 100% | 42.26 | 703 / 705 |
kidney | 100% | 2070.66 | 89 / 89 | 96% | 47.66 | 866 / 901 |
stomach | 95% | 1862.82 | 342 / 359 | 99% | 60.82 | 282 / 286 |
pancreas | 51% | 526.45 | 166 / 328 | 97% | 43.48 | 173 / 178 |
adipose | 100% | 3704.16 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 49.16 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 80.12 | 29 / 29 |
spleen | 100% | 4372.73 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 86.35 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 22.06 | 1 / 1 |
peripheral blood | 100% | 9769.07 | 928 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3866.28 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 66% | 1095.99 | 566 / 861 | 0% | 0 | 0 / 0 |
liver | 8% | 94.94 | 18 / 226 | 56% | 38.54 | 229 / 406 |
muscle | 9% | 87.00 | 71 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006739 | Biological process | NADP metabolic process |
GO_0006098 | Biological process | pentose-phosphate shunt |
GO_0010041 | Biological process | response to iron(III) ion |
GO_0006740 | Biological process | NADPH regeneration |
GO_0043249 | Biological process | erythrocyte maturation |
GO_0009051 | Biological process | pentose-phosphate shunt, oxidative branch |
GO_0014070 | Biological process | response to organic cyclic compound |
GO_2000378 | Biological process | negative regulation of reactive oxygen species metabolic process |
GO_0045471 | Biological process | response to ethanol |
GO_0043523 | Biological process | regulation of neuron apoptotic process |
GO_0019322 | Biological process | pentose biosynthetic process |
GO_0061052 | Biological process | negative regulation of cell growth involved in cardiac muscle cell development |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_1904879 | Biological process | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel |
GO_0021762 | Biological process | substantia nigra development |
GO_0010734 | Biological process | negative regulation of protein glutathionylation |
GO_0032094 | Biological process | response to food |
GO_0051156 | Biological process | glucose 6-phosphate metabolic process |
GO_0006629 | Biological process | lipid metabolic process |
GO_0006695 | Biological process | cholesterol biosynthetic process |
GO_0006006 | Biological process | glucose metabolic process |
GO_0046390 | Biological process | ribose phosphate biosynthetic process |
GO_0006749 | Biological process | glutathione metabolic process |
GO_0034451 | Cellular component | centriolar satellite |
GO_0016020 | Cellular component | membrane |
GO_0009898 | Cellular component | cytoplasmic side of plasma membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0004345 | Molecular function | glucose-6-phosphate dehydrogenase activity |
GO_0050661 | Molecular function | NADP binding |
GO_0005536 | Molecular function | D-glucose binding |
GO_0005515 | Molecular function | protein binding |
Gene name | G6PD |
Protein name | glucose-6-phosphate dehydrogenase (NADP(+)) (EC 1.1.1.49) Glucose-6-phosphate 1-dehydrogenase (EC 1.1.1.49) Glucose-6-phosphate dehydrogenase Glucose-6-phosphate 1-dehydrogenase (G6PD) (EC 1.1.1.49) |
Synonyms | |
Description | FUNCTION: Catalyzes the rate-limiting step of the oxidative pentose-phosphate pathway, which represents a route for the dissimilation of carbohydrates besides glycolysis. The main function of this enzyme is to provide reducing power (NADPH) and pentose phosphates for fatty acid and nucleic acid synthesis. . FUNCTION: Catalyzes the rate-limiting step of the oxidative pentose-phosphate pathway, which represents a route for the dissimilation of carbohydrates besides glycolysis. . FUNCTION: Catalyzes the rate-limiting step of the oxidative pentose-phosphate pathway, which represents a route for the dissimilation of carbohydrates besides glycolysis. . FUNCTION: Catalyzes the rate-limiting step of the oxidative pentose-phosphate pathway, which represents a route for the dissimilation of carbohydrates besides glycolysis. . FUNCTION: Catalyzes the rate-limiting step of the oxidative pentose-phosphate pathway, which represents a route for the dissimilation of carbohydrates besides glycolysis. . FUNCTION: Catalyzes the rate-limiting step of the oxidative pentose-phosphate pathway, which represents a route for the dissimilation of carbohydrates besides glycolysis. . FUNCTION: Catalyzes the rate-limiting step of the oxidative pentose-phosphate pathway, which represents a route for the dissimilation of carbohydrates besides glycolysis. . FUNCTION: Catalyzes the rate-limiting step of the oxidative pentose-phosphate pathway, which represents a route for the dissimilation of carbohydrates besides glycolysis. . FUNCTION: Catalyzes the rate-limiting step of the oxidative pentose-phosphate pathway, which represents a route for the dissimilation of carbohydrates besides glycolysis. . FUNCTION: Catalyzes the rate-limiting step of the oxidative pentose-phosphate pathway, which represents a route for the dissimilation of carbohydrates besides glycolysis. . FUNCTION: Catalyzes the rate-limiting step of the oxidative pentose-phosphate pathway, which represents a route for the dissimilation of carbohydrates besides glycolysis. . FUNCTION: Catalyzes the rate-limiting step of the oxidative pentose-phosphate pathway, which represents a route for the dissimilation of carbohydrates besides glycolysis. . |
Accessions | A0A2H4QGB2 Q2VF42 ENST00000696429.1 [P11413-1] A0A8Q3SJB9 ENST00000696426.1 Q0PHS2 A0A8Q3SIN6 ENST00000696427.1 Q2Q9B7 A0A8Q3WL83 ENST00000696422.1 ENST00000393562.10 [P11413-1] E7EUI8 ENST00000393564.7 [P11413-1] A7IZZ3 A0A8Q3WL90 ENST00000696428.1 Q0PHS5 ENST00000439227.6 ENST00000696431.1 ENST00000696424.1 ENST00000696421.1 Q2Q9H2 A0A8Q3WL93 A0A8Q3WLB9 ENST00000696420.1 Q0PHS4 ENST00000696430.1 [P11413-1] A0A2H4QGB8 Q0PHS3 A0A8Q3WL95 ENST00000696425.1 ENST00000369620.6 [P11413-2] A2IBT6 A0A6G9IW12 A0A8Q3SIS5 A0A8Q3WLT0 ENST00000696423.1 E9PD92 A0A8Q3WL80 ENST00000433845.1 A0A2H4QGB6 B6ZHS6 E7EM57 Q0PHS1 P11413 ENST00000440967.5 Q0PHS6 A0A8G1M3Q3 |